Two Sigma Investments LP Takes $44.10 Million Position in Molina Healthcare, Inc. (NYSE:MOH)

Two Sigma Investments LP acquired a new stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 151,518 shares of the company's stock, valued at approximately $44,099,000. Two Sigma Investments LP owned 0.26% of Molina Healthcare at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Tidal Investments LLC lifted its stake in Molina Healthcare by 19.8% in the fourth quarter. Tidal Investments LLC now owns 8,525 shares of the company's stock valued at $2,481,000 after buying an additional 1,408 shares during the period. Teza Capital Management LLC grew its position in shares of Molina Healthcare by 230.7% during the 4th quarter. Teza Capital Management LLC now owns 2,533 shares of the company's stock worth $737,000 after buying an additional 1,767 shares during the period. Siemens Fonds Invest GmbH increased its stake in shares of Molina Healthcare by 12.5% in the 4th quarter. Siemens Fonds Invest GmbH now owns 2,048 shares of the company's stock valued at $596,000 after acquiring an additional 227 shares in the last quarter. Royal Bank of Canada lifted its position in shares of Molina Healthcare by 18.3% during the 4th quarter. Royal Bank of Canada now owns 105,719 shares of the company's stock valued at $30,770,000 after acquiring an additional 16,360 shares during the period. Finally, Rafferty Asset Management LLC boosted its stake in Molina Healthcare by 9.1% during the fourth quarter. Rafferty Asset Management LLC now owns 6,487 shares of the company's stock worth $1,888,000 after acquiring an additional 543 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Insider Activity at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 89,169 shares of company stock valued at $28,520,995 over the last ninety days. Corporate insiders own 1.10% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Barclays lifted their price target on shares of Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a research note on Friday, April 25th. Mizuho boosted their target price on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Finally, Sanford C. Bernstein started coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price objective for the company. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $365.38.

Molina Healthcare Stock Down 1.6%

Shares of NYSE:MOH traded down $4.94 during mid-day trading on Monday, hitting $304.83. 579,500 shares of the company traded hands, compared to its average volume of 693,778. The stock has a 50-day moving average price of $324.45 and a two-hundred day moving average price of $307.75. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23. The stock has a market cap of $16.52 billion, a P/E ratio of 14.92, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's revenue was up 12.2% on a year-over-year basis. During the same period last year, the business earned $5.73 EPS. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.